LEXAGENE HOLDINGS INC.

Profile

Company Names

LEXAGENE HOLDINGS INC.
STONESHIELD CAPITAL CORP.

Addresses

500 CUMMINGS CTR., SUITE 4550, BEVERLY, MA 01915

440 - 789 WEST PENDER STREET, VANCOUVER, A1 V6C 1H2

Phone Numbers

800-215-1824
604-569-0799

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER ENERGY

Year Incorporated:

2007

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$8,738,260.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-11-01 
$1,600,000.00 
$1,600,000.00 
$0.00 
Debt 
5
2022-02-07 
$4,995,000.00 
$11,470,000.00 
$6,475,000.00 
Equity 
4
2020-09-09 
$1,007,857.00 
$1,659,999.00 
$652,142.00 
Equity 
3
2019-10-29 
$998,828.00 
$2,439,446.00 
$1,440,618.00 
Equity 
2
2019-03-29 
$115,200.00 
$265,840.00 
$150,640.00 
Equity 
1
2010-07-16 
$21,375.00 
$21,375.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALLEN 
AMBROSE 
DIRECTOR
STEVEN 
 
ARMSTRONG 
EXECUTIVE OFFICER
MARK 
CAMPBELL 
EXECUTIVE OFFICER, DIRECTOR
JOSEPH 
CARUSO 
DIRECTOR
MANOHAR 
 
FURTADO 
DIRECTOR
MANOHAR 
FURTADO 
DIRECTOR
KRISTER 
KOTTMEIER 
EXECUTIVE OFFICER, DIRECTOR
STEPHEN 
 
MASTROCOLA 
DIRECTOR
STEPHEN 
MASTROCOLA 
DIRECTOR
JEFFREY 
 
MITCHELL 
EXECUTIVE OFFICER
JEFFREY 
MITCHELL 
EXECUTIVE OFFICER
HANS 
 
RASMUSSEN 
DIRECTOR
DARYL 
 
REBECK 
EXECUTIVE OFFICER, DIRECTOR
DARYL 
REBECK 
EXECUTIVE OFFICER, DIRECTOR
JOHN (JACK) 
 
REGAN 
EXECUTIVE OFFICER, DIRECTOR
JOHN (JACK) 
REGAN 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
SLEZAK 
DIRECTOR
THOMAS 
SLEZAK 
DIRECTOR
THOMAS 
RICHARD 
SLEZAK 
DIRECTOR
TOM 
 
SLEZAK 
DIRECTOR
JANE 
 
SYKES 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Debt 
2022-11-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-29 
D
OTHER ENERGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GLOBAL SECURITIES CORPORATION
NONE